SEB Medical Fund

Fact sheet as of 17 October, 2019

Past performance does not guarantee future performance. The value of investment funds and other financial instruments may rise as well as fall and there is no guarantee you will recover your original investment. Key investor information documents and prospectuses are available on www.sebgroup.lu/funds.

This actively managed equity fund invests globally with focus on companies in the healthcare sector. We use an objective, disciplined investment process to identify what we regard as high quality companies that are favorably valued. Additionally, the market should have a positive attitude towards the company’s shares. Diversification and risk awareness are important elements in portfolio construction. Since the fund invests in securities that are issued in other currencies than the base currency of the fund the return may be affected by changes in the exchange rates.

INVESTMENT TEAM

The fund is managed by the Global Equities team with Maria Werner and Lars Englund as the lead portfolio managers. The team, based in Stockholm, employs a systematic and disciplined investment process.

Performance (USD)

NAV: 7.46 USD (10/17/2019). AuM (M USD):43.57 (9/30/2019)
When calculating the returns the inflation is not taken into account

Return % USD

Accumulated
since
Fund Benchmark*
1 day 0.70 0.81
1 month 1.06 1.25
6 months 5.05 8.25
1 year -2.33 2.48
2 years 5.29 12.48
3 years 22.07 33.37
5 years 27.37 46.09
Year to date 4.36 10.38
Average annual growth
3 years 6.87 10.07
5 years 4.96 7.88

* Benchmark, including dividends

Sector allocation*

*Last updated 10/31/2016. Source: SEB

Largest positions1 Share  %

Merck 7.1
Roche Holding 7.1
GlaxoSmithKline 5.1
Bristol-Myers Squibb 4.7
Gilead Sciences 4.4
Johnson & Johnson 4.2
Celgene 4.1
Zoetis 4.1
Biogen 4.0
Baxter International 3.7
1Last updated 9/30/2019. Source: SEB

risk measures 1

Standard Deviation (Fund)13.2
Standard Deviation (Index)13.3
Tracking error3.08
Sharpe Ratio0.15
Information Ratio-1.24
Alpha-3.83
Beta0.97
Active share58.82
124 months rolling. Last updated 30 September, 2019
2Active share measures the difference between the fund’s and the benchmark’s holdings. From 9/30/2019

Other information

As of 2 November 2016, the fund´s Management company is SEB Investment Management AB. SEB works actively with sustainability and follows the UN Principles for Responsible Investments. Read more at www.sebgroup.com

SEB Medical Fund, 17 October 2019

Key Facts

Year of launch1993
Value at launch (USD)1.00
BenchmarkMSCI World Health Care Net Return Index
Fund Management CompanySEB Investment Management AB
Risk Level (SRRI-scale 1-7)5
ISINLU0047324214
Base CurrencyUSD
Share ClassD (USD)
Morningstar rating
Turnover Ratio0.601
Use of derivativesYes2
1From 9/30/2019
2Derivatives may be used to achieve investment objectives or for hedging.

Dividend

Distributing share class

Costs %

Management Fee1.50
Entry FeeNone
Ongoing Charges11.572
1The ongoing charges include the management fee and constitute payment for fund management, including marketing and distribution. The ongoing charges do not include transaction costs such as brokerage commissions on securities transactions.
2From 15/02/2019

More information

Welcome to contact your financial advisor for more information or visit www.sebgroup.lu.

Important information

This material is prepared by SEB and contains general information regarding financial instruments marketed, sold or solicited by SEB. SEB is the global brand name for Skandinaviska Enskilda Banken AB (publ), its subsidiaries and affiliated companies. Neither this material nor the products described in it are intended for distribution or sale in the United States or to US persons, and any such distribution is not allowed. The offering of shares or units in the funds may also be restricted in other jurisdictions. This document may not be used to make an offer or solicitation with respect to the sale of shares or units where such an offer or solicitation is unlawful. Although the information in this material is based on sources deemed by SEB to be reliable, SEB assumes no liability whatsoever for incorrect or missing information or for any loss, damage or claim arising from the use of this material. Past performance does not guarantee future performance. The value of investment funds and other financial instruments may rise as well as fall and there is no guarantee you will recover your original investment. If you or a fund invests in financial instruments denominated in a foreign currency, changes in currency exchange rates can affect the return on the investment. SEB makes no representation that funds whose share or unit classes aim at hedging the fund’s return from changes in currency exchange rates will succeed in achieving this. Any tax information in this material is based on regulations valid as per the date of this presentation and may be subject to change. Note that any tax information in this material is general. Kindly contact your SEB investment advisor for tax and investment advice appropriate for your situation. You are fully and solely responsible for your investment decision. This material is not intended for or suitable as the sole basis for investment decisions. Instead, you should base your decision on the information in the fund’s product documentation, including its fact sheet, Key Investor Information Document, fund regulations and prospectus. These are available on www.sebgroup.lu/funds. Saturday, October 19, 2019 3:11:13 PM